Shrier Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05M Sell
2,488
-7
-0.3% -$2.79K 0.35% 64
2026
Q2
$904K Sell
2,495
-40
-2% -$13.7K 0.3% 69
2026
Q1
$892K Buy
2,535
+6
+0.2% +$2.14K 0.33% 63
2025
Q4
$828K Buy
+2,529
New +$802K 0.33% 67

Other funds holding AMGN

Shrier Wealth Management's AMGN Position: Q3 2026 in Review

Shrier Wealth Management reduced its Amgen (AMGN) stake by 0.28% in Q3 2026, selling an estimated $2.79K and leaving 2,488 shares worth $1.05M. The position accounts for 0.35% of the portfolio, ranked #64.

Shrier Wealth Management first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,270 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Shrier Wealth Management held 2,488 shares of Amgen worth $1.05M as of Q3 2026.
  • Shrier Wealth Management sold 7 Amgen shares in Q3 2026, an estimated $2.79K.
  • Amgen made up 0.35% of Shrier Wealth Management's portfolio in Q3 2026, its #64 holding.
  • Shrier Wealth Management first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 3,270 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.